Problems in diagnostics of primary aldosteronism - Analysis of the own data

Endokrynologia Polska

Volumn 61, Issue 1, 2010, Pages 2-5

  Myśliwiec, Janusz ^a   Zukowski, Łukasz ^a   Grodzka, Anna ^a   Piłaszewicz, Agata ^a   Dragowski, Szymon ^a   Piekut, Beata ^a   Nikotajuk, Agnieszka ^a   GÓrska, Maria ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Aldosterone; Hypertension; Primary aldosteronism; Renin

Indexed keywords

ALDOSTERONE; RENIN;

ADRENAL INCIDENTALOMA; ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HYPERCORTISOLISM; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; RADIOIMMUNOASSAY; URINALYSIS;

ADRENAL GLAND NEOPLASMS; ADULT; AGED; ALDOSTERONE; COMORBIDITY; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; HYPOKALEMIA; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; RENIN; RETROSPECTIVE STUDIES;

EID: 77950538260     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Rossi GP, Bernini G, Caliumi C et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006; 48:2293-3000. (Pubitemid 44873058)
2. Mulatero P, Stowasser M, Loh KC et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centres from five continents. J Clin Endocrinol Metab 2004; 89:1045-1050. (Pubitemid 38368386)
3. Stowasser M, Gordon RD, Gunasekera TG et al. High rate of detection of primary aldosteronism including surgically treatable forms, after non selective screening of hypertensive patients. J Hypertens 2003; 21:2149-2157. (Pubitemid 38296877)
4. Calhoun DA. Resistant or difficult-to-treat hypertension. J Clin Hypertens (Greenwich) 2006; 8:181-186.
5. Douma S, Petidis K, Doumas M. et al. Prevalence of primary hyperaldo- steronism in resistant hypertension: a retrospective observational study. Lancet 2008; 371: 1921-1926. (Pubitemid 351778191)
6. Mulatero P, Rabbia F, Milan A et aL Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension 2002; 40: 897-902. (Pubitemid 35434913)
7. Funder JW, Carey RM, Fardella C et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008; 93:3266-3281.
8. Walz MK, Gwosdz R, Levin SL et al. Retroperitoneoscopic adrenalectomy in Conn's syndrome caused by adrenal adenomas or nodular hyperplasia. World J Surg 2008; 32:847-853.
9. Fritsch NM, Schiffrin EL. Aldosterone: a risk factor for vascular disease. Curr Hypertens 2003; 5:59-65. (Pubitemid 38898933)
10. Pu Q, Neves MF, Virdis A et al. Endothelin antagonism on aldosterone- -induced oxidative stress and vascular remodeling. Hypertension 2003; 42:49-55. (Pubitemid 36849598)
11. Nishizaka MK, Pratt-Ubunama M, Zaman MA et al. Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension. Am J Hypertens 2005; 18: 805- 812. (Pubitemid 40745266)
12. Rossi GP, Seccia TM, Pessina AC. Primary aldosteronism: prevalence, screening, and selection of cases for adrenal vein sampling. J Nephrol 2008; 21:447-454.
13. Lumachi F, Ermani M, Basso SM et al. Long-term results of adrenalectomy in patients with aldosterone-producing adenomas: multivariate analysis of factors affecting unresolved hypertension and review of the lite- rarure Am Surg 2005; 71:864-869.
14. Pang TC, Bambach C, Monaghan JC et al. Outcomes of laparoscopic adrenalectomy for hyperaldosteronism. ANZ J Surg 2007; 77: 768- -773.